Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells

Lignende værker

• β-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells
  af: Yi, Yong Weon, et al.
  Udgivet: (2015)
• Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6
  af: YI, YONG WEON, et al.
  Udgivet: (2015)
• ZSTK474, a PI3K inhibitor, Suppresses Proliferation and Sensitizes to Gemcitabine in Human Pancreatic Adenocarcinoma Cells
  af: DUONG, HONG-QUAN, et al.
  Udgivet: (2011)
• Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer
  af: Tao, Jessica J., et al.
  Udgivet: (2014)
• Inhibition of Constitutively Activated Phosphoinositide 3-Kinase/AKT Pathway Enhances Antitumor Activity of Chemotherapeutic Agents in Breast Cancer Susceptibility Gene 1-Defective Breast Cancer Cells
  af: Yi, Yong Weon, et al.
  Udgivet: (2012)